PharmaCorp Rx (PCRX.V) Stock Price
PharmaCorp Rx Price
PharmaCorp Rx's net margin stands at -6.8%, up from -18.1% several years earlier. Analysts set a median price target of 0.66 CAD, implying 65.8% above the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
PharmaCorp Rx stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
PharmaCorp Rx business model & stock analysis
Frequently asked questions about PharmaCorp Rx
Analysts currently set an average price target of 0.66 CAD for the PharmaCorp Rx stock (median: 0.66 CAD), implying +65.8 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the PharmaCorp Rx stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect PharmaCorp Rx to generate revenue of 50.61 M CAD and earnings per share of 0.01 CAD.
Converted at the current exchange rate, the PharmaCorp Rx share trades at 0.25 EUR (0.40 CAD).
The expected revenue of PharmaCorp Rx is 50.61 M CAD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of PharmaCorp Rx is 1.74 M CAD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of PharmaCorp Rx is currently 26.95. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the PharmaCorp Rx stock.
The price-to-sales ratio (P/S) of PharmaCorp Rx is currently 0.93. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the PharmaCorp Rx stock.
The Eulerpool Quality Score for PharmaCorp Rx is 2/10.
The ISIN of PharmaCorp Rx is CA71714X1050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of PharmaCorp Rx is PCRX.V. The ticker symbol is used to trade PharmaCorp Rx shares on the stock exchange.
PharmaCorp Rx stock
PharmaCorp Rx Peer Group
All fundamentals and in-depth analysis of PharmaCorp Rx
Our stock analysis for PharmaCorp Rx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaCorp Rx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.